Did you know 80% of clinical trials fail to enroll on time? Ergomed’s Rare Disease Site Advantage™ addresses this challenge with a specialized operational model that provides rare disease sites with the resources they need to succeed.
Our model offers comprehensive support, including targeted training on protocol and lab procedures, strategic patient recruitment and retention planning, and thorough logistical preparation for first patient visits. By fostering best practices across treatment centers, we ensure consistency and quality in trial execution.
Why Choose Ergomed’s Rare Disease Site Advantage™?
For biotech and pharma companies, our Rare Disease Site Advantage™ is an invaluable asset to streamline complex rare disease studies. With Ergomed’s dedicated support, your rare disease trial is positioned for successful patient enrollment and retention, ensuring timely and effective trial outcomes.